GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.024x

Based on the latest financial reports, GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a cash flow conversion efficiency ratio of 0.024x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs362.20 Million ≈ $3.92 Million USD) by net assets (Rs15.40 Billion ≈ $166.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GlaxoSmithKline Pharmaceuticals Limited net asset quality index to measure how much of total assets are equity-financed.

GlaxoSmithKline Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how GlaxoSmithKline Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of GlaxoSmithKline Pharmaceuticals Limited to evaluate the quality of earnings relative to operating cash generation.

GlaxoSmithKline Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GlaxoSmithKline Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Investec PLC JSE:INP	-0.202x
Argo Investments Ltd AU:ARG	0.016x
GRINM Semiconductor Materials Co. Ltd. A SHG:688432	N/A
DEME Group NV BR:DEME	0.154x
Cathay Biotech Inc SHG:688065	-0.003x
ADT Inc NYSE:ADT	0.168x
Global Business Travel Group Inc NYSE:GBTG	-0.009x
PERSIMMON UNSPON. ADR 2 F:OHP0	N/A

Annual Cash Flow Conversion Efficiency for GlaxoSmithKline Pharmaceuticals Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see GlaxoSmithKline Pharmaceuticals Limited market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs19.51 Billion ≈ $211.03 Million	Rs12.90 Billion ≈ $139.50 Million	0.661x	+101.90%
2024-03-31	Rs17.78 Billion ≈ $192.24 Million	Rs5.82 Billion ≈ $62.94 Million	0.327x	+17.74%
2023-03-31	Rs17.41 Billion ≈ $188.31 Million	Rs4.84 Billion ≈ $52.37 Million	0.278x	-8.66%
2022-03-31	Rs26.63 Billion ≈ $287.99 Million	Rs8.11 Billion ≈ $87.68 Million	0.304x	-21.03%
2021-03-31	Rs14.99 Billion ≈ $162.12 Million	Rs5.78 Billion ≈ $62.50 Million	0.386x	+43.09%
2020-03-31	Rs18.21 Billion ≈ $196.89 Million	Rs4.90 Billion ≈ $53.05 Million	0.269x	+44.35%
2019-03-31	Rs21.40 Billion ≈ $231.41 Million	Rs3.99 Billion ≈ $43.19 Million	0.187x	-18.79%
2018-03-31	Rs20.57 Billion ≈ $222.49 Million	Rs4.73 Billion ≈ $51.13 Million	0.230x	+95.43%
2017-03-31	Rs20.07 Billion ≈ $217.03 Million	Rs2.36 Billion ≈ $25.52 Million	0.118x	+43.29%
2016-03-31	Rs16.96 Billion ≈ $183.42 Million	Rs1.39 Billion ≈ $15.05 Million	0.082x	-25.74%
2015-03-31	Rs24.44 Billion ≈ $264.32 Million	Rs2.70 Billion ≈ $29.21 Million	0.111x	-21.83%
2014-03-31	Rs19.90 Billion ≈ $215.18 Million	Rs2.81 Billion ≈ $30.42 Million	0.141x	-9.52%
2013-03-31	Rs20.07 Billion ≈ $217.03 Million	Rs3.14 Billion ≈ $33.91 Million	0.156x	-9.88%
2012-03-31	Rs19.36 Billion ≈ $209.34 Million	Rs3.36 Billion ≈ $36.30 Million	0.173x	-29.41%
2011-03-31	Rs19.52 Billion ≈ $211.06 Million	Rs4.79 Billion ≈ $51.84 Million	0.246x	-14.23%
2010-03-31	Rs17.86 Billion ≈ $193.16 Million	Rs5.12 Billion ≈ $55.32 Million	0.286x	+36.72%
2009-03-31	Rs15.76 Billion ≈ $170.39 Million	Rs3.30 Billion ≈ $35.69 Million	0.209x	-9.28%
2008-03-31	Rs13.81 Billion ≈ $149.33 Million	Rs3.19 Billion ≈ $34.48 Million	0.231x	+7.57%
2007-03-31	Rs12.05 Billion ≈ $130.29 Million	Rs2.59 Billion ≈ $27.97 Million	0.215x	-41.44%
2006-03-31	Rs9.53 Billion ≈ $103.08 Million	Rs3.49 Billion ≈ $37.78 Million	0.367x	+47.85%
2005-03-31	Rs9.24 Billion ≈ $99.90 Million	Rs2.29 Billion ≈ $24.77 Million	0.248x	--

About GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO India Drug Manufacturers - General

Market Cap

$4.88 Billion

Rs451.01 Billion INR

Market Cap Rank

#3610 Global

#162 in India

Share Price

Rs2662.30

Change (1 day)

+0.26%

52-Week Range

Rs2103.20 - Rs2863.80

All Time High

Rs3466.20